Mostrar el registro sencillo del ítem
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
dc.contributor.author | Nadeu, Ferrán | |
dc.contributor.author | Clot, G. | |
dc.contributor.author | Delgado, J. | |
dc.contributor.author | Suárez Puente, Xosé Antón | |
dc.contributor.author | López Otín, Carlos | |
dc.date.accessioned | 2017-12-14T11:04:01Z | |
dc.date.available | 2017-12-14T11:04:01Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Leukemia,32, p. 645-653(2018); doi:10.1038/leu.2017.291 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | http://hdl.handle.net/10651/44859 | |
dc.description.sponsorship | This study was supported by the Instituto de Salud Carlos III (ISCIII) PMP15/00007; Ministerio de Economía y Competitividad (MINECO) SAF2015-64885-R; Generalitat de Catalunya AGAUR 2014-SGR-795; and Gilead Spain (GLD15/00288). ECa is an Academia Researcher of the 'Institució Catalana de Recerca i Estudis Avançats' (ICREA) of the Generalitat de Catalunya. FN is supported by a pre-doctoral fellowship of the MINECO (BES-2016-076372). We are indebted to the Genomics core facility of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). We are grateful to N Villahoz and MC Muro for their excellent work in the coordination of the CLL Spanish Consortium, and also thank C Capdevila, S Guijarro, L Pla and M Sánchez for their excellent technical assistance. We are also very grateful to all patients with CLL who have participated in this study. | |
dc.description.statementofresponsibility | Nadeu, F., Clot, G., Delgado, J., Martín-García, D., Baumann, T., Salaverria, I., Beà, S., Pinyol, M., Jares, P., Navarro, A., Suárez-Cisneros, H., Aymerich, M., Rozman, M., Villamor, N., Colomer, D., González, M., Alcoceba, M., Terol, M.J., Navarro, B., Colado, E., Payer, Á., Puente, X.S., López-Otín, C., López-Guillermo, A., Enjuanes, A., Campo, E. | |
dc.format.extent | p. 645-653 | |
dc.language.iso | eng | |
dc.relation.ispartof | Leukemia | |
dc.rights | © The Author(s) 2017 | |
dc.rights | CC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | WOS:000404127001016 | |
dc.title | Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia | |
dc.type | journal article | |
dc.identifier.doi | 10.1038/leu.2017.291 | |
dc.relation.projectID | ISCII/PMP15/00007 | |
dc.relation.projectID | MINECO/SAF2015-64885-R | |
dc.relation.projectID | MINECO/BES-2016-076372 | |
dc.relation.publisherversion | https://doi.org/10.1038/leu.2017.291 | |
dc.rights.accessRights | open access |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [36390]
-
Bioquímica y Biología Molecular [268]
-
Investigaciones y Documentos OpenAIRE [8027]
Publicaciones resultado de proyectos financiados con fondos públicos